人人终身学习知识网~是各类综合知识资源信息分享,提升综合素质与提高知识技能的终身学习网络平台

 找回密码
 立即注册

QQ登录

只需一步,快速开始

微信登录

微信扫码,快速开始

国家药监局正式批准首个四价流感疫苗上市

[复制链接]

China's drug regulator has approved the country's first vaccine that can protect people from four influenza virus strains.

中国药品监管机构近日批准了国内首个能够保护人们不被4种流感病株感染的疫苗。

The four-strain vaccine adds protection against the Yamagata lineage of Influenza B, which was the main virus strain during the last flu season, according to the National Drug Administration of China.

国家药品监督管理局称,这种四价疫苗加入能预防上次流感季中的主要病株B乙型Yamagata流感的抗体。

Two domestic companies -- Hualan and Changsheng -- are the approved vaccine producers. The vaccine may be used on adults and children aged three years and above.

华兰和长春两家国内公司获批成为这种疫苗的生产商。该疫苗或适用于成年人及3岁以上的儿童。

回复

使用道具 举报

小黑屋/人人终身学习知识网~是各类综合知识资源信息分享,提升综合素质与提高知识技能的终身学习网络平台

Powered by 5wangxiao

© 2007-2021 5wangxiao.Com Inc.

快速回复 返回顶部 返回列表